These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 9565115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP, Brown JP, Roe SM, Sprouse LR, Yancey AE, Witherspoon LE.
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stereotactic core needle biopsy and the workup of mammographic breast lesions.
    Devia A, Murray KA, Nelson EW.
    Arch Surg; 1997 May; 132(5):512-5; discussion 515-7. PubMed ID: 9161394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
    White RR, Halperin TJ, Olson JA, Soo MS, Bentley RC, Seigler HF.
    Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G, Cederbom G, Champagne J, Farr G, McKinnon W, Bolton J, Ordoyne WK.
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate.
    Lee CH, Philpotts LE, Horvath LJ, Tocino I.
    Radiology; 1999 Jul; 212(1):189-94. PubMed ID: 10405741
    [Abstract] [Full Text] [Related]

  • 13. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ, Voruganti T, Overbeeke C, Kirshenbaum MD, Patel P, Kaplan G, Maker V, August C, Cavallino RP.
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Follow-up of benign results of stereotactic core breast biopsy.
    Adler DD, Light RJ, Granstrom P, Hunter TB, Hunt KR.
    Acad Radiol; 2000 Apr; 7(4):248-53. PubMed ID: 10766097
    [Abstract] [Full Text] [Related]

  • 16. Effect on biopsy technique of the breast imaging reporting and data system (BI-RADS) for nonpalpable mammographic abnormalities.
    Ball CG, Butchart M, MacFarlane JK.
    Can J Surg; 2002 Aug; 45(4):259-63. PubMed ID: 12174979
    [Abstract] [Full Text] [Related]

  • 17. Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses.
    Charles M, Edge SB, Winston JS, Hurd TC, Driscoll DL, Stomper PC.
    Cancer; 2003 May 01; 97(9):2137-41. PubMed ID: 12712464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer.
    Kaufman CS, Delbecq R, Jacobson L.
    World J Surg; 1998 Oct 01; 22(10):1023-7; discussion 1028. PubMed ID: 9747160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.